MedPath

HUNTINGTON MEDICAL RESEARCH INSTITUTES

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
http://www.hmri.org/

Empagliflozin Significantly Reduces Stroke Size in Preclinical Studies

Researchers found that empagliflozin (EMPA), an antidiabetic drug, dramatically reduced the size of cerebral infarctions in preclinical stroke models.

© Copyright 2025. All Rights Reserved by MedPath